The Central Drugs Standard Control Organization on Friday reportedly issued an alert on 60 medicines for being substandard. The drugs that failed the standard test include popular painkiller 'Combiflam' and cold medicine 'D Cold Total.' Notably, the annual revenue of Combiflam alone is estimated to be Rs 169.2 crore.
